Kena C. Miller - Concepedia

Author

Kena C. Miller

Roswell Park Comprehensive Cancer Center

Also Known As

K Miller, K. C. Miller, K. Miller, Kate A. Miller, Kena C Miller, Kena C. Miller, Kena C. Miller, RN, MSN, ARNP-BC, Kena Miller, Kurt Miller

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Mayo Clinic in Florida Mayo Clinic in Arizona WinnMed University of Southern California

About

Kena C. Miller is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	341
2	Health Sciences	5	5	162
3	Cell Biology	3	3	79
4	Nursing	1	1	17
5	Epidemiology	1	1	20

Kena C. Miller

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study Asher Chanan‐Khan, Kena C. Miller, Laurie Musial, Journal of Clinical Oncology	2006	408
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study Asher Chanan‐Khan, Jonathan L. Kaufman, Jayesh Mehta, Blood	2006	255
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL) Asher Chanan‐Khan, Kena C. Miller, Kenichi Takeshita, Blood	2005	104
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma Myron S. Czuczman, Alexandra Fallon, Alice Mohr, Seminars in Oncology Lymphoid NeoplasiaLow-grade LymphomaMedicinePathologyLymphatic Disease	2002	97
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response Asher Chanan‐Khan, Kena C. Miller, David Lawrence, Cancer	2010	87
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics Taimur Sher, Kena C. Miller, David Lawrence, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicineHigh-risk Cytogenetics	2010	82
Acyclovir Prophylaxis Against Varicella Zoster Virus Reactivation in Multiple Myeloma Patients Treated With Bortezomib-Based Therapies: A Retrospective Analysis of 100 Patients Abhisek Swaika, Aneel Paulus, Kena C. Miller, The Journal of Supportive Oncology	2012	37
<scp>AT</scp>‐101 downregulates <scp>BCL</scp>2 and <scp>MCL</scp>1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and <scp>W</scp>aldenström macroglobulinaemia Aneel Paulus, Kasyapa S. Chitta, Sharoon Akhtar, British Journal of Haematology	2013	36
Maintaining Bone Health in Patients With Multiple Myeloma Teresa Miceli, Kathleen Colson, Beth Faiman, Clinical journal of oncology nursing Bone DiseaseBone HealthOncologyOrthopaedic SurgeryHealth Sciences	2011	35
Long-Term Survival With Allogeneic Stem Cell Transplant and Donor Lymphocyte Infusion Following Salvage Therapy with Anti-CD52 Monoclonal Antibody (Campath) in a Patient with α/β Hepatosplenic T-Cell Non-Hodgkin's Lymphoma Asher Chanan‐Khan, Tariq Islam, Arif Alam, Leukemia & lymphoma/Leukemia and lymphoma	2004	35

Page 1